10.1007/s40204-021-00160-9

In-vitro cellular and in-vivo investigation of ascorbic acid and β-glycerophosphate loaded gelatin/sodium alginate injectable hydrogels for urinary incontinence treatment

  • Hessam Rezaei1,
  • Azadeh Asefnejad*1,
  • Morteza Daliri-Joupari2,
  • Sedigheh Joughehdoust3,
  1. Department of Biomedical Engineering, Science and Research Branch, Islamic Azad University, Tehran, IR
  2. National Institute of Genetic Engineering and Biotechnology, Tehran, IR
  3. Department of Urology, School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, NL Faculty of Science and Engineering, Aachen-Maastricht Institute for Biobased Materials, Maastricht University, Geleen, NL

Published in Issue 2021-06-24

How to Cite

Rezaei, H., Asefnejad, A., Daliri-Joupari, M., & Joughehdoust, S. (2021). In-vitro cellular and in-vivo investigation of ascorbic acid and β-glycerophosphate loaded gelatin/sodium alginate injectable hydrogels for urinary incontinence treatment. Progress in Biomaterials, 10(2 (June 2021). https://doi.org/10.1007/s40204-021-00160-9
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Abstract Urinary incontinence is one of the most common disorders especially in adult women. In this study, cellular and in-vivo analyses were performed on (3-glycidyloxypropyl) trimethoxysilane (GPTMS) and CaCl 2 cross-linked alginate and gelatin hydrogels containing β-glycerophosphate and ascorbic acid to evaluate the regenerative potential as injectable compression agents for the treatment of urinary incontinence. The hydrogels were prepared with different percentages of components and were named as GA1 (7.2% w/v gelatin, 6% w/v sodium alginate, 0.5:1w/w GPTMS, CaCl 2 1% (wt) sodium alginate, 50 μg/mL ascorbic acid, 1.5 mg/mL β-glycerophosphate), GA2 (10% w/v gelatin, 8.5% w/v sodium alginate, 0.5:1 w/w GPTMS, CaCl 2 1% (wt) sodium alginate, 50 μg/mL ascorbic acid, 1.5 mg/mL β-glycerophosphate), and GA3 (10% (w/v) gelatin, 8.5% w/v sodium alginate, 1:1 w/w GPTMS, CaCl 2 1% (wt) sodium alginate, 50 μg/mL ascorbic acid, 1.5 mg/mL β-glycerophosphate) hydrogels. The results of cell studies showed that although all three samples supported cell adhesion and survival, the cellular behavior of the GA2 sample was better than the other samples. Animal tests were performed on the optimal GA2 sample, which showed that this hydrogel repaired the misfunction tissue in a rat model within 4 weeks and the molecular layer thickness was reached the normal tissue after this duration. It seems that these hydrogels, especially GA2 sample containing 10% (w/v) gelatin, 8.5% (w/v) sodium alginate, 0.5:1 (w/w) GPTMS, CaCl 2 1% (wt) sodium alginate, 50 μg/mL ascorbic acid, and 1.5 mg/mL β-glycerophosphate, can act as an injetable hydrogel for urinary incontinence treatment without the need for repeating the injection.

Keywords

  • Sodium alginate,
  • Gelatin,
  • Injectable hydrogels,
  • GPTMS,
  • Urinary incontinence

References

  1. Arabi et al. (2018) The tunable porous structure of gelatin-bioglass nanocomposite scaffolds for bone tissue engineering applications: physicochemical, mechanical, and in-vitro properties https://doi.org/10.1002/mame.201700539
  2. Coelho and Fernandes (2000) Human bone cell cultures in biocompatibility testing Part II: effect of ascorbic acid, β-glycerophosphate and dexamethasone on osteoblastic differentiation (pp. 1095-1102) https://doi.org/10.1016/S0142-9612(99)00192-1
  3. Davis et al. (2013) Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents (pp. 913-919) https://doi.org/10.1007/s00192-012-2011-9
  4. Ding et al. (2015) Amorphous calcium phosphate nanowires prepared using beta-glycerophosphate disodium salt as an organic phosphate source by a microwave-assisted hydrothermal method and adsorption of heavy metals in water treatment (pp. 40154-40162) https://doi.org/10.1039/C5RA04624F
  5. Duan et al. (2013) 3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels (pp. 1255-1264) https://doi.org/10.1002/jbm.a.34420.3D
  6. Elmelund et al. (2019) Patient characteristics that may influence the effect of urethral injection therapy for females stress urinary incontinence (pp. 125-131) https://doi.org/10.1097/JU.0000000000000176
  7. Eui et al. (2005) Poly (lactic-co-glycolic acid) microspheres as a potential bulking agent for urological injection therapy: preliminary results (pp. 166-172) https://doi.org/10.1002/jbm.b.30138
  8. Heang et al. (2006) PCL microparticle-dispersed PLGA solution as a potential injectable urethral bulking agent (pp. 1936-1944) https://doi.org/10.1016/j.biomaterials.2005.09.030
  9. Hurtado et al. (2008) Complications of ethylene vinyl alcohol copolymer as an intraurethral bulking agent in men with stress urinary incontinence (pp. 662-665) https://doi.org/10.1016/j.urology.2007.10.016
  10. Kim et al. (2011) Bioactive porous beads as an injectable urethral bulking agent: in vivo animal study for the treatment of urinary incontinence (pp. 1527-1535) https://doi.org/10.1089/ten.tea.2010.0600
  11. Kirchin et al. (2012) Urethral injection therapy for urinary incontinence in women (pp. 2-4) https://doi.org/10.1002/14651858.CD003881.pub3
  12. Langenbach and Handschel (2013) Effects of dexamethasone, ascorbic acid and β-glycerophosphate on the osteogenic differentiation of stem cells in vitro https://doi.org/10.1186/scrt328
  13. Lapitan and Cody (2016) Open retropubic colposuspension for urinary incontinence in women (pp. 1-17) https://doi.org/10.1002/14651858.CD002912.pub6
  14. Liao et al. (2009) Differential physical, rheological, and biological properties of rapid in situ gelable hydrogels composed of oxidized alginate and gelatin derived from marine or porcine sources (pp. 1263-1271) https://doi.org/10.1007/s10856-009-3694-4
  15. Liu et al. (2020) Cell-loaded injectable gelatin/alginate/LAPONITE® nanocomposite hydrogel promotes bone healing in a critical-size rat calvarial defect model (pp. 25652-25661) https://doi.org/10.1039/d0ra03040f
  16. Luo et al. (2018) 3D printing of concentrated alginate/gelatin scaffolds with homogeneous nano apatite coating for bone tissue engineering (pp. 12-19) https://doi.org/10.1016/j.matdes.2018.03.002
  17. Maione-Silva et al. (2019) Ascorbic acid encapsulated into negatively charged liposomes exhibits increased skin permeation, retention and enhances collagen synthesis by fibroblasts (pp. 1-14) https://doi.org/10.1038/s41598-018-36682-9
  18. Mangır et al. (2015) Production of ascorbic acid releasing biomaterials for pelvic floor repair (pp. 188-197) https://doi.org/10.1016/j.actbio.2015.10.019
  19. Mollaqasem et al. (2020) Incorporation of graphene oxide and calcium phosphate in the PCL/PHBV core-shell nanofibers as bone tissue scaffold https://doi.org/10.1002/app.49797
  20. Movahedi et al. (2020) Potential of novel electro-spun core-shell structured polyurethane/starch (hyaluronic acid) nanofibers for skin tissue engineering: In vitro and in vivo evaluation (pp. 627-637) https://doi.org/10.1016/j.ijbiomac.2019.11.233
  21. Naghizadeh et al. (2018) Self-crosslinking effect of chitosan and gelatin on alginate based hydrogels: injectable in situ forming scaffolds (pp. 256-264) https://doi.org/10.1016/j.msec.2018.04.018
  22. Namdarian et al. (2018) Evaluation of freeze-dry chitosan-gelatin scaffolds with olibanum microspheres containing dexamethasone for bone tissue engineering 42(6) (pp. 982-993) https://doi.org/10.7317/pk.2018.42.6.982
  23. Nouri-Felekori et al. (2019) Comparative analysis and properties evaluation of gelatin microspheres crosslinked with glutaraldehyde and 3-glycidoxypropyltrimethoxysilane as drug delivery systems for the antibiotic vancomycin (pp. 208-220) https://doi.org/10.1016/j.ijpharm.2018.12.054
  24. Oh et al. (2015) Dual growth factor-loaded in situ gel-forming bulking agent: passive and bioactive effects for the treatment of urinary incontinence https://doi.org/10.1007/s10856-014-5365-3
  25. Oliva et al. (2019) Combined ascorbic acid and T3 produce better healing compared to bone marrow mesenchymal stem cells in an Achilles tendon injury rat model: a proof of concept study (pp. 1-10) https://doi.org/10.1186/s13018-019-1098-9
  26. Pilipenko et al. (2019) Tailoring swelling of alginate-gelatin hydrogel microspheres by crosslinking with calcium chloride combined with transglutaminase https://doi.org/10.1016/j.carbpol.2019.115035
  27. Raisi et al. (2020) A soft tissue fabricated using freeze-drying technique with carboxymethyl chitosan and nanoparticles for promoting effects on wound healing (pp. 262-274) https://doi.org/10.22034/JNA.2022.680836
  28. Ramseyer et al. (2010) In vivo study of an injectable poly(acrylonitrile)-based hydrogel paste as a bulking agent for the treatment of urinary incontinence (pp. 4613-4619) https://doi.org/10.1016/j.biomaterials.2010.02.021
  29. Rasti et al. (2019) Effects of GPTMS concentration and powder to liquid ratio on the flowability and biodegradation behaviors of 45S5 bioglass/tragacanth bioactive composite pastes (pp. 17-22) https://doi.org/10.1002/app.47604
  30. Rezaei et al. (2020) The physicochemical and mechanical investigation of siloxane modified gelatin/sodium alginate injectable hydrogels loaded by ascorbic acid and β-glycerophosphate https://doi.org/10.1016/j.mtcomm.2020.101914
  31. Shi et al. (2019) Rapid endothelialization and controlled smooth muscle regeneration by electrospun heparin-loaded polycaprolactone/gelatin hybrid vascular grafts (pp. 2040-2049) https://doi.org/10.1002/jbm.b.34295
  32. Shirosaki et al. (2015) Preparation of porous chitosan–siloxane hybrids coated with hydroxyapatite particles (pp. 1-6) https://doi.org/10.1155/2015/392940
  33. Sohrabi et al. (2020) Enhancing mechanical properties and biological performances of injectable bioactive glass by gelatin and chitosan for bone small defect repair (pp. 1-19) https://doi.org/10.3390/biomedicines8120616
  34. Stevens et al. (2007) A review of materials, fabrication methods, and strategies used to enhance bone regeneration in engineered bone tissues 85(2) (pp. 573-582) https://doi.org/10.1002/jbm.b.30962
  35. Takahashi et al. (2006) Periurethral injection of sustained release basic fibroblast growth factor improves sphincteric contractility of the rat urethra denervated by botulinum-A toxin (pp. 819-823) https://doi.org/10.1016/j.juro.2006.03.070
  36. Uman et al. (2020) Recent advances in shear-thinning and self-healing hydrogels for biomedical applications (pp. 1-20) https://doi.org/10.1002/app.48668
  37. Vardar et al. (2019) A bioactive injectable bulking material; a potential therapeutic approach for stress urinary incontinence (pp. 41-48) https://doi.org/10.1016/j.biomaterials.2019.03.030
  38. Wang and Stegemann (2010) Thermogelling chitosan and collagen composite hydrogels initiated with β-glycerophosphate for bone tissue engineering (pp. 3976-3985) https://doi.org/10.1016/j.biomaterials.2010.01.131
  39. Wang et al. (2017) A novel bioactive osteogenesis scaffold delivers ascorbic acid, β-glycerophosphate, and dexamethasone in vivo to promote bone regeneration (pp. 31612-31625) https://doi.org/10.18632/oncotarget.15779
  40. Wang et al. (2020) Use of bioactive extracellular matrix fragments as a urethral bulking agent to treat stress urinary incontinence (pp. 156-166) https://doi.org/10.1016/j.actbio.2020.09.049
  41. Wen et al. (2014) Mechanically robust gelatin-alginate IPN hydrogels by a combination of enzymatic and ionic crosslinking approaches (pp. 504-513) https://doi.org/10.1002/mame.201300274
  42. Yan et al. (2018) Controlled release of insulin-like growth factor 1 enhances urethral sphincter function and histological structure in the treatment of female stress urinary incontinence in a rat model (pp. 301-312) https://doi.org/10.1111/bju.13985
  43. You SJ, Ahn WS, Jang HS, Il Kang M (2007) Preparation and characterization of gelatin-poly(vinyl alcohol) hydrogels for three-dimensional cell culture. J Ind Eng Chem 13(1):116–120
  44. Yousefichaijan et al. (2018) Efficacy of ascorbic acid supplementation in relief of symptoms due to febrile upper urinary tract infection in children, a clinical trial and hospital based study (pp. 4-9) https://doi.org/10.5812/pedinfect.57071
  45. Yu et al. (2011) A new calcium source for bioactive sol–gel hybrids (pp. 1-3) https://doi.org/10.4303/bda/d110178
  46. Yuan et al. (2017) Injectable photo crosslinked enhanced double-network hydrogels from modified sodium alginate and gelatin (pp. 569-577) https://doi.org/10.1016/j.ijbiomac.2016.12.058
  47. Zhang et al. (2016) Effect of dexamethasone, β-glycerophosphate, OGP and BMP2 in TiO2 nanotubes on differentiation of MSCs (pp. 1-10) https://doi.org/10.1080/10667857.2016.1152655